Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Acamprosate + LY03004
|
DC9X220
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Arfolitixorin + LY03004
|
DCFH555
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Bortezomib + LY03004
|
DCU0C75
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Doxorubicin + LY03004
|
DCC2PYH
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Gefitinib + LY03004
|
DC0JQ6I
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Imipramine + LY03004
|
DCYHDD6
|
Imipramine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
IT-141 + LY03004
|
DCR1VHE
|
IT-141
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Levamisole + LY03004
|
DC3MFF2
|
Levamisole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Baclofen
|
DCU1HRF
|
Baclofen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Diethylcarbamazine
|
DC21U36
|
Diethylcarbamazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Citalopram
|
DCIKM4M
|
Citalopram
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Crotamiton
|
DCY8PP4
|
Crotamiton
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Trioxsalen
|
DC8Q7XZ
|
Trioxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Vinblastine
|
DCYV06N
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Anamorelin
|
DCC5ANJ
|
Anamorelin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Metyrosine
|
DCYXVVE
|
Metyrosine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Guanfacine
|
DC1N6C6
|
Guanfacine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Chlorzoxazone
|
DCMBTQC
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Docetaxel
|
DCX9T72
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + JZL195
|
DCDPLKW
|
JZL195
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Fibrates
|
DC2ZS57
|
Fibrates
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Mecamylamine
|
DCBEZ5G
|
Mecamylamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + BIO-300
|
DC6L2EJ
|
BIO-300
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Trifluoperazine
|
DCC86CB
|
Trifluoperazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Tamoxifen
|
DCJ1P7L
|
Tamoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Pargyline
|
DC3Q6LP
|
Pargyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Idarubicin
|
DC9PF41
|
Idarubicin
|
Glioblastoma? (Cell Line: T98G)
|
[2] |
LY03004 + Pramipexole
|
DC4L6HU
|
Pramipexole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Methylene blue
|
DCVD70S
|
Methylene blue
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Topotecan
|
DCXW328
|
Topotecan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Cefmenoxime
|
DC3WEM1
|
Cefmenoxime
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Maprotiline
|
DC6J1X7
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Leflunomide
|
DCWC44B
|
Leflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Acarbose
|
DCIOVOY
|
Acarbose
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Amiloride
|
DC837XS
|
Amiloride
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Brincidofovir
|
DCDQ5S6
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Asenapine
|
DCPTHQQ
|
Asenapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Quinine
|
DC8YYS4
|
Quinine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Endoxifen
|
DCFIMP6
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Mycophenolic acid
|
DCC8ZS7
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Auranofin
|
DC1W5J2
|
Auranofin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Rufinamide
|
DCYWBCL
|
Rufinamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Vorinostat
|
DC20H7P
|
Vorinostat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Cerivastatin
|
DCRXNG5
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Aciclovir
|
DCBQHFP
|
Aciclovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
LY03004 + Cytarabine
|
DCNHDYN
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
PHA-739358 + LY03004
|
DCRDY2Y
|
PHA-739358
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
PMID28460551-Compound-2 + LY03004
|
DCAU62D
|
PMID28460551-Compound-2
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Raltegravir + LY03004
|
DCU43WK
|
Raltegravir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Ribavirin-TP + LY03004
|
DC6UW4X
|
Ribavirin-TP
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Spironolactone + LY03004
|
DCWD5OG
|
Spironolactone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Tiagabine + LY03004
|
DCZFNJ7
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Trihexyphenidyl + LY03004
|
DCBPMHB
|
Trihexyphenidyl
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|